- Home
- CPOP vs IGC Comparison
CPOP vs IGC Comparison
Compare CPOP & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | IGC |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 31.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPOP | IGC |
|---|---|---|
| Price | $0.45 | $0.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.13 |
| AVG Volume (30 Days) | 50.0K | ★ 936.3K |
| Earning Date | 11-17-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $107,632,769.00 | $1,106,000.00 |
| Revenue This Year | N/A | $3.54 |
| Revenue Next Year | N/A | $15.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 127.16 | N/A |
| 52 Week Low | $0.39 | $0.25 |
| 52 Week High | $2.61 | $0.50 |
Technical Indicators
Market Signals| Indicator | CPOP | IGC |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 37.86 |
| Support Level | $0.42 | $0.29 |
| Resistance Level | $0.48 | $0.31 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 69.31 | 18.27 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.